The difference in perspectives between superpowers is shaping the race for A.I. dominance.

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than ...

OpenAI advances recursive AI; new startup pursues self-improving systems amid leaked experimental model names.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Q1 2026 Management View "Since stepping into this role, I've been focused on a singular question: how do we harness the full power of AI to consistently and with urgency create better medicines for ...

Below is an edited transcript of an episode of “Interesting Times.” We recommend listening to it in its original form for the ...

Nvidia's ( NVDA) first-quarter 2026 earnings report next week should serve as another catalyst for the tech sector, as this ...

Python stays far ahead after another dip; C holds second, Java retakes third from C++, and R rises to eighth as SQL slips, with Delphi steady in tenth. May’s TIOBE Index has one of those charts that ...

Lauren (Hansen) Holznienkemper is a lead editor for the small business vertical at Forbes Advisor, specializing in HR, payroll and recruiting solutions for small businesses. Using research and writing ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...